Momentum Builds in California Pradaxa Suits

This is Amy German, Managing Associate attorney for The Michael Brady Lynch Firm.

Along with the other dedicated attorneys at The Michael Brady Lynch Firm, I have been leading the charge against the dangerous anticoagulant medication Pradaxa by filing new cases for those that did not or could not participate in the MDL settlement. We are spearheading new litigations in Connecticut and Illinois, but Californians should be pleased that their day in court is about to come.

A petition filed in cooperation with The Michael Brady Lynch Firm was granted to have Pradaxa cases coordinated into a Judicial Council Coordinate Proceeding (JCCP). This means that lawsuits filed in any California state court from anywhere in the state are transferred to a single judge in hopes of expediting the process and avoiding ruling inconsistencies.  The judge for this JCCP will be the Honorable Mary E. Wiss.

We are confident that the JCCP under Judge Mary E. Wiss will be the vehicle to help further expose the dangers of Pradaxa already well known. This blood thinner is responsible for causing serious bleeding issues to more than 4,000 people. These bleeds include gastrointestinal, rectal and brain, which have killed over 540 people and thousands of others reported serious harm. Yet, Pradaxa manufacturer, Boehringer Ingelheim still denies any wrongdoing. They continue to deny it to this day, despite agreeing to pay $650 million to resolve over 4,000 cases in a previously settled multi-district lawsuit.

The facts are simple – Boehringer Ingelheim did not adequately label Pradaxa, misled medical care providers and the public in published studies claiming the drug is safer than alternative drugs on the market, failed to establish a bleeding treatment protocol and intentionally concealed the dangers of Pradaxa. All these wrongdoings by Boehringer led to many suffering damaging side effects and even loss of life.

Boehringer may attempt to argue that since an antidote is available now, they should not be made into a villain. However, this antidote has proven to be too little too late. It has only now become an option, which does little to make up for the harm Pradaxa caused prior to its placement on the market. Additionally, for those with severe bleeding injuries, medical professionals choose to not even administer the antidote — which is a telling fact in and of itself.

If you or a loved one suffered a bleeding event after taking Pradaxa, contact us today at 877-513-9517.


Leave a Reply

Your email address will not be published. Required fields are marked *

Contact Us Today

Contact our lawyers directly through the email form below.
  • * Denotes a required field
  • This field is for validation purposes and should be left unchanged.